David van Klaveren

ORCID: 0000-0002-2096-606X

Also affiliated with Huisarts en Wetenschap, Erasmus University Rotterdam

MedicineEconomics, Econometrics and FinanceMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration”.

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration

Annals of Internal Medicine(2020)10.7326/m18-3668

N/A

6.4DataRank · unranked

178 citations

David van Klaveren, Jessica K. Paulus, Rodney Hayward, Bray Patrick-Lake, Sally Morton +15 more

Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained

Acta Diabetologica(2021)10.1007/s00592-021-01672-3

N/A

0.360DataRank · unranked

10 citations

David van Klaveren, Joshua T. Cohen, John B. Wong, Robin Ruthazer, David M. Kent +1 more

Tuning and external validation of an adult congenital heart disease risk prediction model

European Heart Journal - Quality of Care and Clinical Outcomes(2020)10.1093/ehjqcco/qcaa090

N/A

0DataRank · unranked

15 citations

Alexander R. Opotowsky, Cara L. Lachtrupp, Vivan J.M. Baggen, Sarah Brainard, Michael J. Landzberg +5 more

External Validations of Cardiovascular Clinical Prediction Models: A Large-scale Review of the Literature

medRxiv(2021)10.1101/2021.01.19.21250110

N/A

0DataRank · unranked

7 citations

Jason Nelson, Jinny G. Park, Hannah McGinnes, Gaurav Gulati, Riley Brazil +7 more

US and Dutch Perspectives on the Use of COVID-19 Clinical Prediction Models: Findings from a Qualitative Analysis

Medical Decision Making(2023)10.1177/0272989x231152852

N/A

0DataRank · unranked

4 citations

Isabel R. A. Retel Helmrich, Jinny G. Park, Jennifer Polo, Judith Rietjens, David van Klaveren +8 more

Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival difference

medRxiv(2024)10.1101/2024.12.19.24319347

N/A

0DataRank · unranked

2 citations

David M. Kent, Avinash G. Dinmohamed, David van Klaveren, Carolien C. H. M. Maas

Development and validation of a clinical prediction model for hospitalization after emergency department admission in patients with cancer

ESMO Real World Data and Digital Oncology(2025)10.1016/j.esmorw.2025.100141

N/A

0DataRank · unranked

0 citations

David van Klaveren, Jason G.A. den Duijn, Rob J.C.G. Verdonschot, N. Wlazlo, Joachim G.J.V. Aerts +5 more

Estimating the benefits of personalised glycaemic control

The Lancet(2025)10.1016/s0140-6736(25)01235-8

N/A

0DataRank · unranked

0 citations

Patrick W. Serruys, David M. Kent, David van Klaveren

Graphical calibration curves and the integrated calibration index (ICI) for survival models

Statistics in Medicine(2020)10.1002/sim.8570

N/A

0DataRank · unranked

215 citations

Frank E. Harrell, David van Klaveren, Peter C. Austin